AKTX - Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums - Click
AKTX - Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.